India's Piramal Pharma rises on successful completion of USFDA probe

Piramal Pharma (Mumbai)

03/04/2023 05:39

** Shares of Piramal Pharma  PIRM.NS  rise as much as 3.43% to
70.80 rupees
    ** Co says USFDA successfully closes its good manufacturing
practices (GMP) inspection of its Digwal facility
    ** FDA has concluded the probe with zero Form 483
observations - co
    ** Care Ratings on Friday assigned "CARE AA-, stable" rating
to PIRM
    ** ~1.25 mln shares change hands in early trade - Refinitiv
data

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))